Delivery Order SPE2DB20D3103-SPE2DB23FM9B9
Award Date
3/28/23
Potential Completion Date
3/29/23
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,153.24 Firm Fixed Price Delivery Order contract is for the provision of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract has an ultimate completion date of November 13, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $5,464.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of EMTRICITABINE-TENOFV 200-300MG UU 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,116.81 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg prescription medication. The award has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,145.49 firm fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300mg prescription medication. The contract is not designated as a set-aside and has a completion date of June 7, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,066.17 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg medication. The contract has an ultimate completion date of February 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $1,223.20, is a Firm Fixed Price Delivery Order with a performance period through January 23, 2025. The award is for the supply of emtricitabine-tenofovir 200-300mg medication. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a $302,143.59 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567439970 units of the pharmaceutical product emtricitabine-tenofovir 200-300mg, which supports military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.39 Firm Fixed Price Delivery Order (Contract #: SPE2DB20D1109|SPE2DB23FN23R) is for the delivery of Emtricitabine-Tenofovir 200-300mg medications, with a completion date of December 28, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the provision of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific delivery order has a ceiling...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...